HUP0101613A3
(en )
2003-01-28
Metalloprotease inhibitor (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides and medicaments containing the same
HK1094909A1
(en )
2007-04-13
Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis il-18
EG23122A
(en )
2004-04-28
Pyrrolcarboxamides and pyrrolcarbothioamides
IL206621A0
(en )
2010-12-30
Caspase inhibitors and pharmaceutical compositions containing the same
TWI318207B
(en )
2009-12-11
Carbamate caspase inhibitors and uses thereof
HUP0104768A3
(en )
2002-05-28
4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same
GB9800795D0
(en )
1998-03-11
Prevention of multiple use of limited use devices
HK1061851A1
(en )
2004-10-08
Gyrase inhibitors and uses thereof
SI1251848T1
(en )
2004-12-31
Gyrase inhibitors and uses thereof
GB0006721D0
(en )
2000-05-10
Assessment methods and systems
AU2001284690A1
(en )
2002-02-13
Compositions exhibiting synergistic inhibition of the expression and/or activityof cyclooxygenase-2
EP1419785A4
(en )
2005-07-06
Drugs containing chymase inhibitor and ace inhibitor as the active ingredients
IL150383A0
(en )
2002-12-01
Glyburide and pharmaceutical compositions containing the same
IL156577A0
(en )
2004-01-04
Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
HUP0104844A3
(en )
2003-05-28
Anticancer combination compositions containing mitoic inhibitor and mek inhibitor and their use
HUP0103845A3
(en )
2003-04-28
Disinfecting composition and its use
PL360243A1
(en )
2004-09-06
Benzoxazepinones and their use as squalene synthase inhibitors
HUP0302738A3
(en )
2010-01-28
Use of sarp-1 for the treatment and/or prevention of scleroderma
EP1352637A4
(en )
2006-11-02
Hair growth inhibitors and compositions containing the same
GB2337518B
(en )
2003-10-08
Dissolution inhibitor of chemically amplified photoresist and chemically amplified photoresist composition containing the same
GB0007530D0
(en )
2000-05-17
Trityl-type compounds and their use
GB0021497D0
(en )
2000-10-18
Compounds and their use
HU0203768D0
(en )
2003-01-28
Combination containing cgmpe inhibitor and gabapentine or pregabaline
EP1305017A4
(en )
2004-01-14
Methods and compositions for the prevention and treatment of syndrome x
AU5104101A
(en )
2001-10-15
Composition and use